GSK023
GSK023 (compound 31) is a selective chemical probe targeting the BET BD1 domain[1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/gsk023.html
Solubility
10 mM in DMSO
Smiles
O=C1C(C)=CC(C2=NC3=CC=CC=C3N2C[C@H]4CN(C(C5CCN(C(C)C)CC5)=O)CCC4)=CN1C
Molecular Formula
C29H39N5O2
Molecular Weight
489.65
References & Citations
[1]Bradley E et al. Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical Probe. J Med Chem. 2023 Nov 15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042146-100 1x 100 µL
PU.1 (SPI-1) (B-Cell Marker) (PU1/2146), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402474-100 1x 100 µL
CD103 / Integrin alpha E (T-Cell Lymphoma & Hairy Cell Leukemia Marker) (ITGAE/2474), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682746-100 1x 100 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
